These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32524727)

  • 1. Low-density-lipoprotein apheresis-mediated endothelial activation therapy to severe-peripheral artery disease study: Rationale and study design.
    Ueda E; Toya Y; Wakui H; Kawai Y; Azushima K; Fujita T; Saigusa Y; Yamanaka T; Yabuki Y; Mikami T; Goda M; Sugano T; Tamura K
    Ther Apher Dial; 2020 Oct; 24(5):524-529. PubMed ID: 32524727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein apheresis in patients with peripheral artery disease and lipoprotein(a)-hyperlipoproteinemia: 2-year follow-up of a prospective single center study.
    Poller WC; Berger A; Dreger H; Morgera S; Enke-Melzer K
    Atheroscler Suppl; 2017 Nov; 30():174-179. PubMed ID: 29096834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results.
    Weiss N; Julius U
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):39-44. PubMed ID: 30875001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.
    Tamura K; Tsurumi-Ikeya Y; Wakui H; Maeda A; Ohsawa M; Azushima K; Kanaoka T; Uneda K; Haku S; Azuma K; Mitsuhashi H; Tamura N; Toya Y; Tokita Y; Kokuho T; Umemura S
    Ther Apher Dial; 2013 Apr; 17(2):185-92. PubMed ID: 23551675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia.
    Wu MD; Moccetti F; Brown E; Davidson BP; Atkinson T; Belcik JT; Giraud G; Duell PB; Fazio S; Tavori H; Tsimikas S; Lindner JR
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1430-1440. PubMed ID: 29909101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein Apheresis Alleviates Treatment-Resistant Peripheral Artery Disease Despite the Normal Range of Atherogenic Lipoproteins: The LETS-PAD Study.
    Ueda E; Toya Y; Wakui H; Ishiga K; Kawai Y; Kobayashi R; Kinguchi S; Kanaoka T; Saigusa Y; Mikami T; Yabuki Y; Goda M; Machida D; Fujita T; Haruhara K; Sugano T; Azushima K; Tamura K
    J Atheroscler Thromb; 2024 Apr; ():. PubMed ID: 38569869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
    Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
    Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL apheresis in Japan.
    Makino H; Tamanaha T; Harada-Shiba M
    Transfus Apher Sci; 2017 Oct; 56(5):677-681. PubMed ID: 28964708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apheresis to Mitigate Atherosclerotic Vascular Disease.
    Sachais BS; Shaz BH
    Am J Hypertens; 2018 Jul; 31(8):945-949. PubMed ID: 30016414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein apheresis in patients with peripheral artery disease and hyperlipoproteinemia(a).
    Poller WC; Dreger H; Morgera S; Berger A; Flessenkämper I; Enke-Melzer K
    Atheroscler Suppl; 2015 May; 18():187-93. PubMed ID: 25936325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
    Koizumi J; Koizumi I; Uno Y; Inazu A; Kajinami K; Haraki T; Yagi K; Kamon N; Miyamoto S; Takegoshi T
    Atherosclerosis; 1993 Apr; 100(1):65-74. PubMed ID: 8318064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
    Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
    Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
    Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
    Kroon AA; van Asten WN; Stalenhoef AF
    Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination treatment using percutaneous transluminal angioplasty and low-density lipoprotein apheresis in a patient with peripheral arterial disease and a history of chronic hemodialysis.
    Nishimura H; Enokida H; Tsuruta M; Yoshino Y; Yamada Y; Sugita S; Hayashi S; Arata K; Hayami H; Nishiyama K; Nakagawa M
    J Clin Apher; 2013 Aug; 28(4):330-4. PubMed ID: 23450792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of different low-density lipoprotein apheresis methods.
    Parhofer KG; Geiss HC; Schwandt P
    Ther Apher; 2000 Oct; 4(5):382-5. PubMed ID: 11111821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
    Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
    Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.